Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.61 |
| ▸ | HPGD | P15428 | 2/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 1/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.61 |
| ▸ | LCK | P06239 | 1/20 | 0.46 |
| ▸ | G6PD | P11413 | 1/20 | 0.45 |
| ▸ | CASP7 | P55210 | 1/20 | 0.45 |
| ▸ | CASP6 | P55212 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | CES2 | O00748 | 1/20 | 0.43 |
| ▸ | BCHE | P06276 | 1/20 | 0.43 |
| ▸ | CES1 | P23141 | 1/20 | 0.43 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.42 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.42 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.42 |
| ▸ | METAP2 | P50579 | 1/20 | 0.42 |
| ▸ | HSD17B14 | Q9BPX1 | 3/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27214503 | 0.86 | ALDH1A1 (0.52) | KDM4EALDH1A1HPGDMAPTTSHR | |
| SCHEMBL27730957 | 0.83 | KDM4E (0.52) | KDM4EALDH1A1HPGDMAPTTSHR | |
| SCHEMBL10956901 | 0.82 | HSD17B1 (0.50) | KDM4EALDH1A1HPGDMAPTTSHR | |
| SCHEMBL29528396 | 0.80 | CES2 (0.68) | KDM4EALDH1A1HPGDMAPTTSHR | |
| SCHEMBL10457470 | 0.80 | KDM4E (0.46) | KDM4EALDH1A1HPGDMAPTTSHR | |
| SCHEMBL203112 | 0.80 | CES2 (0.68) | KDM4EALDH1A1HPGDMAPTTSHR | |
| SCHEMBL5231025 | 0.80 | ALDH1A1 (0.60) | KDM4EALDH1A1HPGDTSHRHSD17B10 | |
| SCHEMBL1067211 | 0.78 | THRB (0.52) | KDM4EALDH1A1HPGDMAPTTSHR | |
| SCHEMBL30623038 | 0.78 | MMP2 (0.45) | KDM4EALDH1A1HPGDMAPTTSHR | |
| Ammonia Solution, Strong SCHEMBL30995385 | 0.78 | KDM4E (0.45) | KDM4EALDH1A1HPGDMAPTTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102531946-A | 3-methoxybenzamide (MBA) derivant as well as preparation method and application thereof | UNIV SHANDONG | 2012-07-04 | — | — | CN | claimed |
| US-20250179008-A1 | ANTIBACTERIAL AGENTS | TAXIS PHARMACEUTICALS, INC. (US) | 2025-06-05 | — | — | US | disclosed |
| CN-104981469-B | Antimicrobial | 罗格斯新泽西州立大学 | 2018-03-20 | — | — | CN | disclosed |
| CN-107324975-A | Direct hydroxylation or amination method of photocatalytic benzene and derivatives thereof | 中国科学院理化技术研究所 | 2017-11-07 | — | — | CN | disclosed |
| CN-104981469-A | Antimicrobial agents | UNIV RUTGERS | 2015-10-14 | — | — | CN | disclosed |
| US-20150191420-A1 | ANTIBACTERIAL AGENTS | TAXIS PHARMACEUTICALS, INC. | 2015-07-09 | — | — | US | disclosed |
| US-20150191420-A1 | ANTIBACTERIAL AGENTS | TAXIS PHARMACEUTICALS, INC. | 2015-07-09 | — | — | US | disclosed |
| US-20150191420-A1 | ANTIBACTERIAL AGENTS | TAXIS PHARMACEUTICALS, INC. | 2015-07-09 | — | — | US | disclosed |
| US-8865736-B2 | Antibacterial agents | Biota Scientific Pty Ltd (AU) | 2014-10-21 | — | — | US | disclosed |
| US-8865736-B2 | Antibacterial agents | Biota Scientific Pty Ltd (AU) | 2014-10-21 | — | — | US | disclosed |
| US-20100173933-A1 | ANTIBACTERIAL AGENTS | PROLYSIS LTD (GB) | 2010-07-08 | — | — | US | disclosed |
| US-20100173933-A1 | ANTIBACTERIAL AGENTS | PROLYSIS LTD (GB) | 2010-07-08 | — | — | US | disclosed |
| US-20100173933-A1 | ANTIBACTERIAL AGENTS | PROLYSIS LTD (GB) | 2010-07-08 | — | — | US | disclosed |
| CN-101404989-A | Antibacterial agent | PROLYSIS LTD (GB) | 2009-04-08 | — | — | CN | disclosed |
| EP-1996180-A1 | ANTIBACTERIAL AGENTS | Prolysis Limited (GB) | 2008-12-03 | — | — | EP | disclosed |
| WO-2007107758-A1 | ANTIBACTERIAL AGENTS | PROLYSIS LTD (GB) | 2007-09-27 | — | — | WO | disclosed |
| WO-2007107758-A1 | ANTIBACTERIAL AGENTS | PROLYSIS LTD (GB) | 2007-09-27 | — | — | WO | disclosed |
| CN-1580055-A | Quinolone carboxylic acid derivatives and their salts | XINCHUANG MEDICINE SCIENCE TEC (CN) | 2005-02-16 | — | — | CN | disclosed |
| CN-1028226-C | 4-Oxoquinoline-3-carboxylic acid derivatives, their preparation and their use | UBE INDUSTRIES (JP) | 1995-04-19 | — | — | CN | disclosed |
| CN-1040977-A | The preparation and the use of 4-Oxoquinoline-3-carboxylic acid derivative | UBE INDUSTRIES (JP) | 1990-04-04 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150191420-A1 | ANTIBACTERIAL AGENTS | ALK, ARG1, ROS1 | KDM4E 1251/4885ALDH1A1 740/4885HPGD 3902/4885 |
| US-20250179008-A1 | ANTIBACTERIAL AGENTS | ALK, ROS1, NOX1 | KDM4E 2407/4885ALDH1A1 800/4885HPGD 3468/4885 |
| US-20100173933-A1 | ANTIBACTERIAL AGENTS | ALK, ROS1, NOX1 | KDM4E 2407/4885ALDH1A1 800/4885HPGD 3468/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.